Navigation Links
HIV Drugs Provide Breast-Fed Babies With Some Protection
Date:7/22/2009

Treating infected mothers, giving meds to infant both beneficial in African study

WEDNESDAY, July 22 (HealthDay News) -- Antiretroviral drugs appear safe and effective in helping prevent the transmission of HIV from mother to child through breast milk, a new international study has found.

The researchers found that giving daily antiretroviral syrup to breast-feeding infants or putting their HIV-infected mothers on highly active antiretroviral drugs significantly lowered the child's chances of contracting the virus that causes AIDS. The chance of a mother with HIV transmitting the virus through breast-feeding is about one in five.

The results of the Breastfeeding, Antiretrovirals and Nutrition (BAN) study, conducted in more than 2,000 HIV-infected mother-child pairs in Malawi in Africa, are scheduled to be presented in South Africa Wednesday at the 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.

"This is an exciting development," lead investigator Dr. Charles van der Horst, a professor in the University of North Carolina School of Medicine, said in a university news release. "We may be able to spare mothers in the developing world a horrible choice by offering them an effective method for preventing transmission of HIV during breast-feeding."

Breast milk is the source of infection for about half of the 420,000 infants who are infected with HIV annually, the study authors noted. This is a particular problem in some poor countries where HIV-infected mothers risk infecting their babies or having to use more expensive formula that is also subject to contamination from local water supplies.

In the BAN study, HIV-infected mothers and their babies were randomly assigned to one of three groups: infant antiretroviral syrup, maternal medication, or no treatment following birth. After 28 weeks, 7.6 percent of the infants in the group that did not receive any treatment had HIV or died, compared with 4.7 percent of infants whose mothers took antiretroviral medication, and 2.9 percent of the infants taking the antiretroviral syrup, the researchers found.

More information

The University of North Carolina School of Medicine has more about the BAN study.



-- Kevin McKeever



SOURCE: University of North Carolina School of Medicine, news release, July 22, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New review suggests caution on drugs to raise good cholesterol
2. Can cancer drugs combine forces?
3. Study provides hope that some transplant patients could live free of antirejection drugs
4. Study provides hope that some transplant patients could live free of anti-rejection drugs
5. RA Drugs Linked to Slight Skin Cancer Risk
6. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
7. Rock N Roll: Sex, Drugs and an Early Exit
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
10. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
11. 2 drugs equally effective for heart patients undergoing angioplasty, Mayo study finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV Drugs Provide Breast-Fed Babies With Some Protection
(Date:4/21/2017)... ... 2017 , ... Chicago plastic surgeon, Dr. Anil R. Shah, MD , ... benign bony lump located on the forehead usually attributed to a facial fracture. Their ... pain. Dr. Shah has discovered an approach that is minimally invasive. He is an ...
(Date:4/21/2017)... ... 2017 , ... Young Asset Protection, an insurance provider and ... greater Pittsburgh metropolitan region, is joining forces with the local chapter of the ... , Variety the Children’s Charity is a national organization dedicated to empowering, enabling, ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of The Beryl Institute ... 2017 Ruth Ravich Patient Advocacy Award in recognition of her extraordinary contributions to ... the award at The Beryl Institute’s annual Patient Experience Conference on March ...
(Date:4/21/2017)... ... April 21, 2017 , ... Crossover Symmetry ... O2X , an active lifestyle company that provides Human Performance Training and education ... police offers, first responders, military officers and others in service through the development ...
(Date:4/21/2017)... ... April 21, 2017 , ... Airway ... new partnership with the highly regarded and well renowned Asian distributor, Discovery Sleep. ... & myTAP PAP Nasal Pillow Mask, and will stabilize and strengthen Airway’s presence ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 The Mobile X-Ray product segment is the ... during the forecast period Mobile X-Ray segment is ... mobile X-Ray devices market, which is estimated to be valued ... a CAGR of 7% over the forecast period. Mobile X-Ray ... than US$ 100 Mn in 2017 over 2016. The segment,s ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
Breaking Medicine Technology: